Session 2 Glioblastoma
Case Presentation - Long Term Response to Bevacizumab to an Initially Resistant Glioblastoma
Date
29 Nov 2018Session
Session 2 GlioblastomaPresenters
A. Tarek, FRResources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Case Presentation - Progression or Pseudoprogression?
Presenter: D. Machado, PT
Session: Session 2 Glioblastoma
Resources:
Slides
Webcast
Standards of Care - Glioblastoma
Presenter: M. Weller, CH
Session: Session 2 Glioblastoma
Resources:
Slides
Webcast
Future Developments - Glioblastoma
Presenter: M. Weller, CH
Session: Session 2 Glioblastoma
Resources:
Slides
Webcast